HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients

HER2-Low Status Is Not Accurate in Breast Cancer Core Needle Biopsy Samples: An Analysis of 5610 Consecutive Patients

Background: HER2-Low status is found in approximately half of breast cancer patients and shows potential benefits from novel antibody–drug conjugates (ADCs). Data on the accuracy of HER2-Low status between core needle biopsy (CNB) and surgical excision specimen (SES) samples are lacking. We aimed to...

Full description

Bibliographic Details
Main Authors: Yujie Lu, Siji Zhu, Yiwei Tong, Xiaochun Fei, Wu Jiang, Kunwei Shen, Xiaosong Chen
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
breast cancer
HER2-Low
concordance
core needle biopsy
surgical excision samples
Online Access:https://www.mdpi.com/2072-6694/14/24/6200

Internet

https://www.mdpi.com/2072-6694/14/24/6200

Similar Items